| Detailed information |
|---|
| CancerLivER ID | 2140 |
| Biomarker | miR-18b* |
| Biomarker Name/Symbol (given in Publication) | miR-18b* |
| Biomolecule | miRNA |
| Subject | Human |
| Degree of Validity | Potential biomarkers for diagnosis of HCC; but not validated on independent datasets |
| Experimental Condition | Normal v/s HCC/HCV/HBV |
| Cancer type | Hepatocellular carcinoma |
| Regulation | Downregulated in the HCC v/s non-tumor (with fold change 0.21) |
| Level of significance | p < 0.001 |
| Source | Tissue |
| PMID | 23205106 |
| Type of Biomarker | Diagnostic |
| Pathway | NA |
| Cohort | 40 primary HCC patients and 6 metastatic liver cancer patients. |
| Sensitivity | NA |
| Specificity | NA |
| Accuracy | NA |
| AUC | NA |
| Disease | Human HCC |
| Year of Publication | 2012 |
| Clinical trial | NO |
| Clinical trial (NCT Number) | NA |